In the News
'Lazarus drug' may have competition in MI Important reporting about the harmful push to get other opioid overdose formulations more widely available in Michigan. These new formulations/medications (high-dose naloxone and nalmefene) will massively harm affected community members and not reduce overdose deaths. NOTE: Naloxone has been working
Some insight into our principles and how they affect business operations
In the News
People deserve to know how this money will be spent to save lives and make our community safe for everyone.
In the News
The use of fear to push products that will hurt people instead of helping them is disgusting.
Digital Health
A must-read for those who say these privacy violations are not intentional and that these companies "mean well."
Digital Health
The Tate Chronicles: Dr Jonathan Stoltman, Director at the Opioid Policy Institute Great to chat with Jim Tate about our opioid addiction privacy work and the role of opioid settlement money in stemming the addiction crisis we're facing. 🔊27min listen
Digital Health
A hub for the key data related to privacy & opioid addiction treatment and recovery websites Report 2 series.
Digital Health
Mo money mo problems
Digital Health
The first domino in addiction privacy enforcement?
In the News
Immigration policy treats people who use drugs or have an addiction as undesirable. This doesn't recognize the widespread drug use in the United States or the science that addiction is a treatable chronic disease. For many, this is an "out of sight, out of mind" issue,
Reporting on Addiction
Michigan opioid settlement dollars sit unspent as crisis rages Highlighting the issue in Michigan with spending the opioid settlement money, lack of transparency, and the urgent need to spend the money.
In the News
Reporting on Addiction Talking Reporting on Addiction, a collaboration between the Opioid Policy Institute and 100 Days in Appalachia. We talk about how we started and where we're going. 45 minutes🔉